Genetic 'fingerprint' may ID breast cancer patients likely to benefit from potentially toxic chemo, study finds
A genetic ‘fingerprint’ may ID breast cancer patients likely to benefit from potentially toxic chemo, a Standford Medicine study finds. Conversely, these drugs could be avoided if it was known a patient was unlikely to benefit from their use.
If you would like to read more about this study, click the link below: